Celsius

Bitget sees largest market share growth after FTX bankruptcy

Retrieved on: 
Thursday, January 19, 2023
Ethereum, Fed, Face, Celsius, Total value, FTX, Merkle tree, Boston, History, Growth, Pension Protection Fund, BSC, Bankruptcy, Decentralized finance, Boston Consulting Group, TVL, Cryptocurrency

VICTORIA, Seychelles, Jan. 19, 2023 /PRNewswire/ -- Leading crypto derivatives exchange Bitget has become one of the world's top 3 crypto exchanges in the derivatives sector paired with enormous achievements, such as a 2.6x market share increase and 8 million registered users in 100+ countries globally, despite the poor market sentiment after FTX's bankruptcy in 2022.

Key Points: 
  • 2022 was one of the roughest years in the crypto industry, which saw the collapse of Terra LUNA, Celsius, and FTX, consequently wiping out over US$2 trillion from the crypto market.
  • According to the latest data shared by the TokenInsight report , Bitget's market share increased dramatically from 3% to 11% after the collapse of the former second-largest exchange, FTX, marked the single largest market share growth in the crypto derivatives sector.
  • Gracy Chen, Managing Director of Bitget remarks "2022 marked one of the most important years in the history of Bitget.
  • We will also continue to expand our spot markets and improve our overall capabilities to optimize the trading experience on Bitget.

Celsius Therapeutics to Present Preclinical Data on Anti-TREM1 Antibody for Inflammatory Bowel Disease at 2023 Crohn’s & Colitis Congress

Retrieved on: 
Thursday, January 19, 2023
Biotechnology, Pharmaceutical, Oncology, General Health, Health, Genetics, Clinical Trials, Other Health, Inflammation, SCOPE, Therapy, Trial of the century, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Biology, IBD, Food, Inflammatory bowel disease, Patient, RNA, Cancer, B cell, Pharmaceutical industry, Celsius

Celsius Therapeutics, a biotechnology company pioneering new precision medicines for patients with cancer and inflammatory disease by harnessing the power of single-cell RNA sequencing and human biology at scale, today announced that new data on CEL383, a potential first-in-class anti-TREM1 antibody for the treatment of inflammatory bowel disease (IBD), has been selected for oral presentation at the 6th Annual Crohn’s & Colitis Congress, taking place January 19-21, 2023, in Denver, Colorado.

Key Points: 
  • Celsius Therapeutics, a biotechnology company pioneering new precision medicines for patients with cancer and inflammatory disease by harnessing the power of single-cell RNA sequencing and human biology at scale, today announced that new data on CEL383, a potential first-in-class anti-TREM1 antibody for the treatment of inflammatory bowel disease (IBD), has been selected for oral presentation at the 6th Annual Crohn’s & Colitis Congress, taking place January 19-21, 2023, in Denver, Colorado.
  • “These data demonstrate the power of our SCOPE platform (Single Cell Observations for Precision Effect) to create promising new therapeutics in IBD and other diseases,” said Tariq Kassum, M.D., President and CEO of Celsius.
  • “We anticipate filing an investigational new drug application for CEL383 with the U.S. Food and Drug Administration and commencing a Phase 1 clinical study in the first half of this year.

CORE SCIENTIFIC DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Core Scientific, Inc. and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, January 12, 2023
Class Action Lawsuit, Professional Services, Legal, Celsius Network, News, Person, District court, P.C, Research, Jeanne Eagels, Telephone, Defendant, Court, Bankruptcy, Griffin, Cryptocurrency, Celsius

Investors have until January 13, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until January 13, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • Core Scientific is a blockchain computing data center provider and digital asset mining company.
  • On this news, Core Scientific’s stock fell $0.72, or 9.4%, to close at $6.98 on March 3, 2022, thereby injuring investors.
  • On this news, Core Scientific’s stock price fell $0.15, or 10.3%, to close at $1.30 on September 29, 2022, thereby injuring investors.

Breaking News for Core Scientific, Inc. Investors: Lawsuit filed on behalf of investors; Portnoy Law Firm

Retrieved on: 
Thursday, January 12, 2023
News, Person, Mining, SPAC, Research, Defendant, Griffin, Celsius

LOS ANGELES, Jan. 12, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Core Scientific, Inc. (NASDAQ: CORZ) (NASDAQ: CORZW) investors that lawsuit filed on behalf of all persons and entities that purchased, or otherwise acquired Core Scientific securities between January 3, 2022 and October 26, 2022. Core Scientific investors that lost money on their investment are encouraged to contact Lesley Portnoy, Esq.

Key Points: 
  • Core Scientific investors that lost money on their investment are encouraged to contact Lesley Portnoy, Esq.
  • The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.
  • On this news, Core Scientific's stock fell $0.72, or 9%, to close at $6.98 on March 3, 2022, thereby injuring investors.
  • The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing.

CORZ IMPORTANT DEADLINE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Core Scientific, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important January 13 Deadline in Securities Class Action – CORZ

Retrieved on: 
Wednesday, January 11, 2023
Titan, Celsius Network, Advertising, Class, Court, I-Space (Chinese company), Griffin, Insurance, Celsius

WHAT TO DO NEXT: To join the Core Scientific class action, go to https://rosenlegal.com/submit-form/?case_id=3932 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the Core Scientific class action, go to https://rosenlegal.com/submit-form/?case_id=3932 or call Phillip Kim, Esq.
  • If you wish to serve as lead plaintiff, you must move the Court no later than January 13, 2023.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

BTCS Announces Private Beta Release of its Staking-as-a-Service Platform “StakeSeeker” as well as Enhanced IR Website

Retrieved on: 
Tuesday, January 10, 2023
Staking, Celsius, FTX, Safety, Risk, Spring, Coinbase, Decentralized finance, BTCS, Cryptocurrency, Kraken, Binance, MD

Silver Spring, MD, Jan. 10, 2023 (GLOBE NEWSWIRE) -- BTCS Inc. (Nasdaq: BTCS) (“BTCS” or the “Company”), a blockchain technology-focused company, announced today the private beta launch of its proprietary Digital Asset Analytic and Staking-as-a-Service Platform: StakeSeeker ( www.stakeseeker.com ).

Key Points: 
  • Silver Spring, MD, Jan. 10, 2023 (GLOBE NEWSWIRE) -- BTCS Inc. (Nasdaq: BTCS) (“BTCS” or the “Company”), a blockchain technology-focused company, announced today the private beta launch of its proprietary Digital Asset Analytic and Staking-as-a-Service Platform: StakeSeeker ( www.stakeseeker.com ).
  • The private beta will allow us to solicit feedback and work through any issues prior to a formal public beta launch.
  • Existing users of the legacy Data Analytics Platform will have their accounts migrated to the new platform beta.
  • New users interested in joining can sign up on www.stakeseeker.com to join the private beta.

CORE SCIENTIFIC, INC. (NASDAQ: CORZ) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Core Scientific, Inc. (NASDAQ: CORZ)

Retrieved on: 
Tuesday, January 10, 2023
Celsius Network, News, District court, Research, Labour government, Court, Bankruptcy, The Legal 500, Advertising, Investment, Griffin, Security (finance), Cryptocurrency, Celsius

NEW YORK, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of Core Scientific, Inc. (“Core Scientific” or the “Company”) (NASDAQ: CORZ) between January 3, 2022 and October 26, 2022, inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the Western District of Texas and alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • The lawsuit was filed in the United States District Court for the Western District of Texas and alleges violations of the Securities Exchange Act of 1934.
  • Core Scientific is a blockchain computing data center provider and digital asset mining company.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Rent, Core Scientific, Torrid, and Olaplex and Encourages Investors to Contact the Firm

Retrieved on: 
Monday, January 9, 2023
Celsius Network, News, Form, Register, Education, Face, COVID-19, Piper Sandler Companies, CFO, Griffin, Jewellery, Government, RTR, Hair, IPO, Risk, NYSE, Prospectus, Research, Maintenance, Rent the Runway, Registration statement, Defendant, Marketing, Growth, Lilliput Kidswear, CURV, Bankruptcy, Complaint, Acquisition, Investment, P.C, Enviva, Pharmaceutical industry, Security (finance), Cryptocurrency, Renewable energy, Audit, Celsius, Overweight, Delta

On this news, Core Scientific’s stock fell $0.72, or 9.4%, to close at $6.98 on March 3, 2022, thereby injuring investors.

Key Points: 
  • On this news, Core Scientific’s stock fell $0.72, or 9.4%, to close at $6.98 on March 3, 2022, thereby injuring investors.
  • On this news, Core Scientific’s stock price fell $0.15, or 10.3%, to close at $1.30 on September 29, 2022, thereby injuring investors.
  • For more information on the Enviva class action go to: https://bespc.com/cases/CORZ
    Torrid is a direct-to-consumer brand of women's plus-size apparel and intimates.
  • As of the time this complaint was filed, the price of Olaplex common stock continues to trade below the Offering price of $21.00 per share, damaging investors.

DEADLINE ALERT for VWE, CORZ, and RENT: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Retrieved on: 
Monday, January 9, 2023
Transport, EBITDA, Register, COVID-19, Law, RTR, Vintage Wine, Registration statement, Defendant, Marketing, Suite, Investment, Griffin, Mail, Pharmaceutical industry, Risk management, Celsius

LOS ANGELES, Jan. 09, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.

Key Points: 
  • LOS ANGELES, Jan. 09, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.
  • Investors have until the deadlines listed below to file a lead plaintiff motion.
  • Investors suffering losses on their investments are encouraged to contact The Law Offices of Frank R. Cruz to discuss their legal rights in these class actions at 310-914-5007 or by email to [email protected] .
  • The Law Offices of Frank R. Cruz, Los Angeles

Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Core Scientific, Inc. (CORZ) Investors and Encourages Investors to Contact the Firm Before January 13, 2022

Retrieved on: 
Tuesday, January 10, 2023
Class Action Lawsuit, Professional Services, Legal, Celsius Network, News, Kirby, District court, Research, Douglas v. U.S. District Court ex rel Talk America, Bankruptcy, Court, Griffin, Cryptocurrency, Renewable energy, Private investigator, Celsius

Investors have until January 13, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until January 13, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • Core Scientific is a blockchain computing data center provider and digital asset mining company.
  • It mines digital assets for its own account and provides hosting services for other large-scale miners.
  • Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation.